©2025-2036 All
Rights Reserved.
Online Journal of Bioinformatics. You may not store
these pages in any form except for your own personal use. All other usage or
distribution is illegal under international copyright treaties. Permission to use any of these pages in any other way besides the
before mentioned must be gained in writing from the publisher. This
article is exclusively copyrighted in its entirety to OJB publications. This
article may be copied once but may not be reproduced or re-transmitted without
the express permission of the editors.
OJB©
Online Journal of Bioinformatics©
Onl J Bioinform©
Established 1995
ISSN 1443-2250
Volume 27 (2) : 125-146, 2026.
RNA-dependent RNA polymerase
inhibitors against Japanese encephalitis virus by virtual screening, MM/GBSA
and molecular dynamics simulation.
Akshay Kumar Shukla1,
Mohd Saeed2, Vivek
Dhar Dwivedi3*, Ramesh Chandra Tripathi1*
1Department of
Biological Sciences, Faculty of Science and Environment, Mahatma Gandhi Chitrakoot Gramodaya Vishwavidyalaya, Chitrakoot, Satna, India,2Department of Biology, College of
Science, University of Hail, Hail, Saudi Arabia.3Bioinformatics
Research Division, Quanta Calculus, Greater Noida, India Correspondence: Vivek
Dhar Dwivedi: vivek_bioinformatics@yahoo.com Ramesh Chandra Tripathi: rctbsmgcgv2@gmail.com
ABSTRACT
Shukla AK, Saeed M, Dwivedi VD, Tripathi RC., RNA-dependent RNA polymerase inhibitors against
Japanese encephalitis virus by virtual screening, MM/GBSA and molecular dynamics
simulation., Onl J Bioinform.,
27 (2) : 125-146,
2026. Japanese encephalitis virus (JEV) is a mosquito-borne flavivirus that is a major cause of viral encephalitis in
Asia and the Western Pacific, causing considerable morbidity and mortality
despite the availability of effective vaccines. The absence of approved
antiviral therapies points to the urgent need to find new therapeutic agents
that target critical viral proteins. In the present study, an integrated
computational approach was employed to screen an Approved Drug Analog Compound
Library against potential inhibitors for the RNA-dependent RNA polymerase (RdRp) domain of the JEV NS5 protein. A hierarchical virtual
screening workflow was used to prioritize the top candidates, including
high-throughput virtual screening (HTVS), Glide standard precision (SP) and
extra precision (XP) docking, and MM/GBSA binding free energy calculations. The
top 3 performing compounds were then subjected to 100 ns molecular dynamics
simulations and trajectory-based MM/GBSA analyses to probe the stability of the
protein-ligand complexes. Among the screened compounds, F6617-8473, F6617-8464,
and F2173-1125 demonstrated superior docking scores and binding free energies
compared with the reference inhibitor Galidesivir.
These compounds interacted stably with key catalytic residues (Arg460, Arg474,
Tyr610, Cys714, Arg742, Trp800, and Ile802) and also displayed good structural
stability during the simulation, as indicated by the RMSD, RMSF, radius of gyration, solvent-accessible surface area, and
protein-ligand interaction analysis. Trajectory MM/GBSA calculations further
confirmed their high binding affinities, with F6617-8473 exhibiting the most favorable binding free energy. Together, these results
highlight F6617-8473, F6617-8464, and F2173-1125 as promising lead compounds
against JEV RdRp and lay a strong foundation for
further experimental validation and the development of novel antiviral
therapeutics against Japanese encephalitis virus.
Keywords: Japanese
encephalitis virus, RdRp, Drug discovery, Molecular
simulation.
FULL-TEXT (SUBSCRIBE OR PURCHASE TITLE)